Cyclomodulins in urosepsis strains of Escherichia coli

Journal of Clinical Microbiology

Volumn 48, Issue 6, 2010, Pages 2122-2129

  Dubois, Damien ^a,b   Delmas, Julien ^a,b   Cady, Anne ^c   Robin, Frédéric ^a,b   Sivignon, Adeline ^b   Oswald, Eric ^d,e,f,g   Bonnet, Richard ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f IHAP   (France)

^g UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIAL TOXIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLE INHIBITING FACTOR; CYTOLETHAL DISTENDING TOXIN B I; CYTOLETHAL DISTENDING TOXIN B IV; CYTOLETHAL DISTENDING TOXIN B V; CYTOTOXIC NECROTIZING FACTOR 1; GENTAMICIN; NALIDIXIC ACID; NORFLOXACIN; PKS TOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES; FEMALE; GENE FUNCTION; GENE LOCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; STRAIN DIFFERENCE; UROSEPSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; DNA FINGERPRINTING; DNA, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS; YOUNG ADULT;

ESCHERICHIA COLI; EUKARYOTA;

EID: 77952896651     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02365-09     Document Type: Article

References (71)

1. Adamus-Bialek, W., A. Wojtasik, M. Majchrzak, M. Sosnowski, and P. Parniewski. 2009. (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR. J. Clin. Microbiol. 47:3937-3944.
2. Albert, M. J., S. M. Faruque, A. S. Faruque, K. A. Bettelheim, P. K. Neogi, N. A. Bhuiyan, and J. B. Kaper. 1996. Controlled study of cytolethal distending toxin-producing Escherichia coli infections in Bangladeshi children. J. Clin. Microbiol. 34:717-719.
3. Bidet, P., A. Metais, F. Mahjoub-Messai, L. Durand, M. Dehem, Y. Aujard, E. Bingen, X. Nassif, and S. Bonacorsi. 2007. Detection and identification by PCR of a highly virulent phylogenetic subgroup among extraintestinal pathogenic Escherichia coli B2 strains. Appl. Environ. Microbiol. 73:2373-2377.
4. Bielaszewska, M., M. Fell, L. Greune, R. Prager, A. Fruth, H. Tschape, M. A. Schmidt, and H. Karch. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:1812-1816.
5. Bingen-Bidois, M., O. Clermont, S. Bonacorsi, M. Terki, N. Brahimi, C. Loukil, D. Barraud, and E. Bingen. 2002. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect. Immun. 70:3216-3226.
6. Blum, G., V. Falbo, A. Caprioli, and J. Hacker. 1995. Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96. FEMS Microbiol. Lett. 126:189-195.
7. CA-SFM. 2007. Comité de l'Antibiogramme de la Socié té Française de Microbiologie, communiqué 2007. CA-SFM, Paris, France.
8. Chassagne, L., N. Pradel, F. Robin, V. Livrelli, R. Bonnet, and J. Delmas. 2009. Detection of stx1, stx2, and eae genes of enterohemorrhagic Escherichia coli using SYBR Green in a real-time polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 64:98-101.
9. Clark, C. G., S. T. Johnson, R. H. Easy, J. L. Campbell, and F. G. Rodgers. 2002. PCR for detection of cdt-III and the relative frequencies of cytolethal distending toxin variant-producing Escherichia coli isolates from humans and cattle. J. Clin. Microbiol. 40:2671-2674.
10. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
11. Davis, J. M., H. M. Carvalho, S. B. Rasmussen, and A. D. O'Brien. 2006. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect. Immun. 74:4401-4408.
12. De Rycke, J., A. Milon, and E. Oswald. 1999. Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens. Vet. Res. 30:221-233.
13. Dozois, C. M., S. Clement, C. Desautels, E. Oswald, and J. M. Fairbrother. 1997. Expression of P, S, and F1C adhesins by cytotoxic necrotizing factor 1-producing Escherichia coli from septicemic and diarrheic pigs. FEMS Microbiol. Lett. 152:307-312.
14. Duriez, P., O. Clermont, S. Bonacorsi, E. Bingen, A. Chaventre, J. Elion, B. Picard, and E. Denamur. 2001. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 147:1671-1676.
15. Escobar-Páramo, P., O. Clermont, A. B. Blanc-Potard, H. Bui, C. Le Bouguenec, and E. Denamur. 2004. A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol. Biol. Evol. 21:1085-1094.
16. Escobar-Páramo, P., K. Grenet, A. Le Menac'h, L. Rode, E. Salgado, C. Amorin, S. Gouriou, B. Picard, M. C. Rahimy, A. Andremont, E. Denamur, and R. Ruimy. 2004. Large-scale population structure of human commensal Escherichia coli isolates. Appl. Environ. Microbiol. 70:5698-5700.
17. Escobar-Páramo, P., A. Le Menac'h, T. Le Gall, C. Amorin, S. Gouriou, B. Picard, D. Skurnik, and E. Denamur. 2006. Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates. Environ. Microbiol. 8:1975-1984.
18. Gauduchon, V., L. Chalabreysse, J. Etienne, M. Celard, Y. Benito, H. Lepidi, F. Thivolet-Bejui, and F. Vandenesch. 2003. Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J. Clin. Microbiol. 41:763-766.
19. Ge, Z., D. B. Schauer, and J. G. Fox. 2008. In vivo virulence properties of bacterial cytolethal-distending toxin. Cell. Microbiol. 10:1599-1607.
20. Gordon, D. M., O. Clermont, H. Tolley, and E. Denamur. 2008. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ. Microbiol. 10:2484-2496.
21. Guyer, D. M., J. S. Kao, and H. L. Mobley. 1998. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples. Infect. Immun. 66:4411-4417.
22. Hacker, J., U. Hentschel, and U. Dobrindt. 2003. Prokaryotic chromosomes and disease. Science 301:790-793.
23. Herzer, P. J., S. Inouye, M. Inouye, and T. S. Whittam. 1990. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J. Bacteriol. 172:6175-6181.
24. Houdouin, V., S. Bonacorsi, P. Bidet, M. Bingen-Bidois, D. Barraud, and E. Bingen. 2006. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J. Antimicrob. Chemother. 58:748-751.
25. Janka, A., M. Bielaszewska, U. Dobrindt, L. Greune, M. A. Schmidt, and H. Karch. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634-3638.
26. Jauréguy, F., E. Carbonnelle, S. Bonacorsi, C. Clec'h, P. Casassus, E. Bingen, B. Picard, X. Nassif, and O. Lortholary. 2007. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin. Microbiol. Infect. 13:854-862.
27. Johnson, J. R., B. Johnston, M. A. Kuskowski, J. P. Nougayrede, and E. Oswald. 2008. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J. Clin. Microbiol. 46:3906-3911.
28. Johnson, J. R., M. A. Kuskowski, A. Gajewski, S. Soto, J. P. Horcajada, M. T. Jimenez de Anta, and J. Vila. 2005. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J. Infect. Dis. 191:46-50.
29. Johnson, J. R., K. Owens, A. Gajewski, and M. A. Kuskowski. 2005. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J. Clin. Microbiol. 43:6064-6072.
30. Johnson, J. R., F. Scheutz, P. Ulleryd, M. A. Kuskowski, T. T. O'Bryan, and T. Sandberg. 2005. Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clin. Infect. Dis. 40:813-822.
31. Johnson, J. R., and A. L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.
32. Kadhum, H. J., D. Finlay, M. T. Rowe, I. G. Wilson, and H. J. Ball. 2008. Occurrence and characteristics of cytotoxic necrotizing factors, cytolethal distending toxins and other virulence factors in Escherichia coli from human blood and faecal samples. Epidemiol. Infect. 136:752-760.
33. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
34. Lemonnier, M., L. Landraud, and E. Lemichez. 2007. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 31:515-534.
35. Lidin-Janson, G., B. Kaijser, K. Lincoln, S. Olling, and H. Wedel. 1978. The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med. Microbiol. Immunol. 164:247-253.
36. Loukiadis, E., R. Nobe, S. Herold, C. Tramuta, Y. Ogura, T. Ooka, S. Morabito, M. Kerouredan, H. Brugere, H. Schmidt, T. Hayashi, and E. Oswald. 2008. Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. J. Bacteriol. 190:275-285.
37. Mainil, J. G., E. Jacquemin, and E. Oswald. 2003. Prevalence and identity of cdt-related sequences in necrotoxigenic Escherichia coli. Vet. Microbiol. 94: 159-165.
38. 2/M transition. Mol. Microbiol. 50:1553-1567.
39. Middendorf, B., B. Hochhut, K. Leipold, U. Dobrindt, G. Blum-Oehler, and J. Hacker. 2004. Instability of pathogenicity islands in uropathogenic Escherichia coli 536. J. Bacteriol. 186:3086-3096.
40. Munro, P., G. Flatau, A. Doye, L. Boyer, O. Oregioni, J. L. Mege, L. Landraud, and E. Lemichez. 2004. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J. Biol. Chem. 279:35849-35857.
41. Nougayrède, J. P., S. Homburg, F. Taieb, M. Boury, E. Brzuszkiewicz, G. Gottschalk, C. Buchrieser, J. Hacker, U. Dobrindt, and E. Oswald. 2006. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313:848-851.
42. Nowrouzian, F. L., I. Adlerberth, and A. E. Wold. 2006. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect. 8:834-840.
43. Nowrouzian, F. L., A. E. Wold, and I. Adlerberth. 2005. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J. Infect. Dis. 191:1078-1083.
44. Ochman, H., and R. K. Selander. 1984. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157:690-693.
45. Orden, J. A., G. Dominguez-Bernal, S. Martinez-Pulgarin, M. Blanco, J. E. Blanco, A. Mora, J. Blanco, and R. de la Fuente. 2007. Necrotoxigenic Escherichia coli from sheep and goats produce a new type of cytotoxic necrotizing factor (CNF3) associated with the eae and ehxA genes. Int. Microbiol. 10:47-55.
46. Orth, D., K. Grif, M. P. Dierich, and R. Wurzner. 2006. Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects. J. Med. Microbiol. 55:1487-1492.
47. Oswald, E., J. de Rycke, P. Lintermans, K. van Muylem, J. Mainil, G. Daube, and P. Pohl. 1991. Virulence factors associated with cytotoxic necrotizing factor type two in bovine diarrheic and septicemic strains of Escherichia coli. J. Clin. Microbiol. 29:2522-2527.
48. Oswald, E., J. P. Nougayrède, F. Taieb, and M. Sugai. 2005. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 8:83-91.
49. Pandey, M., A. Khan, S. C. Das, B. Sarkar, S. Kahali, S. Chakraborty, S. Chattopadhyay, S. Yamasaki, Y. Takeda, G. B. Nair, and T. Ramamurthy. 2003. Association of cytolethal distending toxin locus cdtB with enteropathogenic Escherichia coli isolated from patients with acute diarrhea in Calcutta, India. J. Clin. Microbiol. 41:5277-5281.
50. 2/M phase. Mol. Microbiol. 24:1095-1107.
51. Perna, N. T., G. Plunkett III, V. Burland, B. Mau, J. D. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfai, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. S. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.
52. Piatti, G., A. Mannini, M. Balistreri, and A. M. Schito. 2008. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J. Clin. Microbiol. 46:480-487.
53. Picard, B., J. S. Garcia, S. Gouriou, P. Duriez, N. Brahimi, E. Bingen, J. Elion, and E. Denamur. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67:546-553.
54. Pickett, C. L., D. L. Cottle, E. C. Pesci, and G. Bikah. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62:1046-1051.
55. Pickett, C. L., R. B. Lee, A. Eyigor, B. Elitzur, E. M. Fox, and N. A. Strockbine. 2004. Patterns of variations in Escherichia coli strains that produce cytolethal distending toxin. Infect. Immun. 72:684-690.
56. Putze, J., C. Hennequin, J. P. Nougayrède, W. Zhang, S. Homburg, H. Karch, M. A. Bringer, C. Fayolle, E. Carniel, W. Rabsch, T. A. Oelschlaeger, E. Oswald, C. Forestier, J. Hacker, and U. Dobrindt. 2009. Genetic structure and distribution of the colibactin genomic island among Enterobacteriaceae. Infect. Immun. 77:4696-4703.
57. Real, J. M., P. Munro, C. Buisson-Touati, E. Lemichez, P. Boquet, and L. Landraud. 2007. Specificity of immunomodulator secretion in urinary samples in response to infection by alpha-hemolysin and CNF1 bearing uropathogenic Escherichia coli. Cytokine 37:22-25.
58. Relman, D. A. 1993. The identification of uncultured microbial pathogens. J. Infect. Dis. 168:1-8.
59. Rippere-Lampe, K. E., M. Lang, H. Ceri, M. Olson, H. A. Lockman, and A. D. O'Brien. 2001. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect. Immun. 69:6515-6519.
60. Rippere-Lampe, K. E., A. D. O'Brien, R. Conran, and H. A. Lockman. 2001. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf1) attenuates the virulence of uropathogenic Escherichia coli. Infect. Immun. 69:3954-3964.
61. Silver, R. P., W. Aaronson, A. Sutton, and R. Schneerson. 1980. Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect. Immun. 29:200-206.
62. Skurnik, D., D. Bonnet, C. Bernede-Bauduin, R. Michel, C. Guette, J. M. Becker, C. Balaire, F. Chau, J. Mohler, V. Jarlier, J. P. Boutin, B. Moreau, D. Guillemot, E. Denamur, A. Andremont, and R. Ruimy. 2008. Characteristics of human intestinal Escherichia coli with changing environments. Environ. Microbiol. 10:2132-2137.
63. Tavechio, A. T., L. R. Marques, C. M. Abe, and T. A. Gomes. 2004. Detection of cytotoxic necrotizing factor types 1 and 2 among fecal Escherichia coli isolates from Brazilian children with and without diarrhea. Mem. Inst. Oswaldo Cruz 99:81-83.
64. Tóth, I., F. Herault, L. Beutin, and E. Oswald. 2003. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J. Clin. Microbiol. 41:4285-4291.
65. Tóth, I., J. P. Nougayrède, U. Dobrindt, T. N. Ledger, M. Boury, S. Morabito, T. Fujiwara, M. Sugai, J. Hacker, and E. Oswald. 2009. Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect. Immun. 77:492-500.
66. Van Bost, S., E. Jacquemin, E. Oswald, and J. Mainil. 2003. Multiplex PCRs for identification of necrotoxigenic Escherichia coli. J. Clin. Microbiol. 41: 4480-4482.
67. Velasco, M., J. P. Horcajada, J. Mensa, A. Moreno-Martinez, J. Vila, J. A. Martinez, J. Ruiz, M. Barranco, G. Roig, and E. Soriano. 2001. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin. Infect. Dis. 33:1682-1686.
68. Vila, J., K. Simon, J. Ruiz, J. P. Horcajada, M. Velasco, M. Barranco, A. Moreno, and J. Mensa. 2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J. Infect. Dis. 186:1039-1042.
69. Wiles, T. J., R. R. Kulesus, and M. A. Mulvey. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11-19.
70. Zdziarski, J., C. Svanborg, B. Wullt, J. Hacker, and U. Dobrindt. 2008. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect. Immun. 76:695-703.
71. Zhang, L., B. Foxman, and C. Marrs. 2002. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J. Clin. Microbiol. 40:3951-3955.